Colorectal Cancer Therapeutics Market Share, Size,Growth Global Current and Future Plans, Future Regional Trend, Leading Players Updates, Industry Demand by Forecast to 2027

Posted on Dec 20 2021 6:45 AM

"The Colorectal Cancer Therapeutics Market report covers segment data, including: type segment, industry segment, channel segment etc. cover different segment Colorectal Cancer Therapeutics Market size, both volume and value. Also cover different industries client’s information, which is very important for the manufacturers. "

Global Colorectal Cancer Therapeutics Market includes Elaborative company profiling of leading players of the Colorectal Cancer Therapeutics market. All of the segments studied in the report are analyzed based on different factors such as market share, revenue, and CAGR. The analysts have also thoroughly analyzed different regions such as North America, Europe, and the Asia Pacific on the basis of production, revenue, and sales in the Colorectal Cancer Therapeutics market. The researchers used advanced primary and secondary research methodologies and tools for preparing this report on the Colorectal Cancer Therapeutics market.

Get a Sample PDF of report - https://www.marketreportsworld.com/enquiry/request-sample/17280797

About Colorectal Cancer Therapeutics Market:

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

Market Analysis and Insights: Global Colorectal Cancer Therapeutics Market

The global Colorectal Cancer Therapeutics market size is projected to reach USD 17070 million by 2026, from USD 12130 million in 2019, at a CAGR of 4.9% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Therapeutics market.

Global Colorectal Cancer Therapeutics

To Understand How COVID-19 Impact is Covered in This Report. Get Sample copy of the report at - : https://www.marketreportsworld.com/enquiry/request-covid19/17280797

Here is List of BEST KEY PLAYERS Listed in Colorectal Cancer Therapeutics Market Report are:-

  • Taiho Pharma
  • Merck KGaA
  • Amgen
  • Takeda
  • Roche
  • Eli Lilly
  • Sanofi
  • Regeneron
  • Bayer
  • Onyx
  • Bristol-Myers Squib
  • Sumitomo Dainippon Pharma
  • Array BioPharma
  • Hutchison MediPharma
  • Jiangsu Hengrui Medicine
  • Jiangsu Chia-Tai Tianqing
  • Suzhou Zelgen Biopharmaceuticals

Inquire more and share questions if any before the purchase on this report at -https://www.marketreportsworld.com/enquiry/pre-order-enquiry/17280797

Colorectal Cancer Therapeutics Market Segmentation By Type:

  • Diagnostics
  • Therapeutics

Colorectal Cancer Therapeutics Market Segmentation By Application:

  • Hospitals
  • Clinic
  • Research institutions

Get a Sample Copy of the Colorectal Cancer Therapeutics Market Report 2021

The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Colorectal Cancer Therapeutics in these regions, from 2015 to 2027, covering

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Colorectal Cancer Therapeutics Market Forecast by regions, type and application, with sales and revenue, from 2021 to 2027. Colorectal Cancer Therapeutics Market Share, distributors, major suppliers, changing price patterns and the supply chain of raw materials is highlighted in the report. Colorectal Cancer Therapeutics Market Size (sales, revenue) forecast by regions and countries from 2021 to 2027 of Colorectal Cancer Therapeutics industry.The global Colorectal Cancer Therapeutics market Growth is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2027. In 2021, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Colorectal Cancer Therapeutics Market Trend for Development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered. Colorectal Cancer Therapeutics Market Report also mentions market share accrued by each product in the Colorectal Cancer Therapeutics market, along with the production growth.

Study Objectives of this report are:

  • To study and analyze the global Colorectal Cancer Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2027.
  • To understand the structure of Colorectal Cancer Therapeutics market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Colorectal Cancer Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Colorectal Cancer Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Colorectal Cancer Therapeutics submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Key Stakeholders

  • Raw material suppliers
  • Distributors/traders/wholesalers/suppliers
  • Regulatory bodies, including government agencies and NGO
  • Commercial research & development (R&D) institutions
  • Importers and exporters
  • Government organizations, research organizations, and consulting firms
  • Trade associations and industry bodies
  • End-use industries

This Colorectal Cancer Therapeutics Market Research/Analysis Report Contains Answers to your following Questions

  • Which Manufacturing Technology is used for Colorectal Cancer Therapeutics? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
  • Who Are the Global Key Players in This Colorectal Cancer Therapeutics Market? What are Their Company Profile, Their Product Information, and Contact Information?
  • What Was Global Market Status of Colorectal Cancer Therapeutics Market? What Was Capacity, Production Value, Cost and PROFIT of Colorectal Cancer Therapeutics Market?
  • What Is Current Market Status of Colorectal Cancer Therapeutics Industry? What’s Market Competition in This Industry, Both Company, and Country Wise? What’s Market Analysis of Colorectal Cancer Therapeutics Market by Taking Applications and Types in Consideration?
  • What Are Projections of Global Colorectal Cancer Therapeutics Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
  • What Is Colorectal Cancer Therapeutics Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
  • What Is Economic Impact On Colorectal Cancer Therapeutics Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
  • What Are Market Dynamics of Colorectal Cancer Therapeutics Market? What Are Challenges and Opportunities?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Colorectal Cancer Therapeutics Industry?

Purchase this report (Price 3900 USD for a single-user license) –https://www.marketreportsworld.com/purchase/17280797

Detailed TOC of Global Colorectal Cancer Therapeutics Market Report 2021

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Research institutions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Colorectal Cancer Therapeutics Market Perspective (2016-2027)
2.2 Colorectal Cancer Therapeutics Growth Trends by Regions
2.2.1 Colorectal Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Therapeutics Industry Dynamic
2.3.1 Colorectal Cancer Therapeutics Market Trends
2.3.2 Colorectal Cancer Therapeutics Market Drivers
2.3.3 Colorectal Cancer Therapeutics Market Challenges
2.3.4 Colorectal Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Therapeutics Revenue
3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2020
3.5 Colorectal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Colorectal Cancer Therapeutics Market Size (2016-2027)
6.2 North America Colorectal Cancer Therapeutics Market Size by Type
6.2.1 North America Colorectal Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Therapeutics Market Size by Application
6.3.1 North America Colorectal Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Therapeutics Market Size by Country
6.4.1 North America Colorectal Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Colorectal Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Therapeutics Market Size by Type
7.2.1 Europe Colorectal Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Therapeutics Market Size by Application
7.3.1 Europe Colorectal Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Therapeutics Market Size by Country
7.4.1 Europe Colorectal Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Colorectal Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Therapeutics Market Size by Type
9.2.1 Latin America Colorectal Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Therapeutics Market Size by Application
9.3.1 Latin America Colorectal Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Therapeutics Market Size by Country
9.4.1 Latin America Colorectal Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Taiho Pharma
11.1.1 Taiho Pharma Company Details
11.1.2 Taiho Pharma Business Overview
11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Introduction
11.1.4 Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.1.5 Taiho Pharma Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Colorectal Cancer Therapeutics Introduction
11.2.4 Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.2.5 Merck KGaA Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Colorectal Cancer Therapeutics Introduction
11.3.4 Amgen Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Colorectal Cancer Therapeutics Introduction
11.4.4 Takeda Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Therapeutics Introduction
11.5.4 Roche Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Colorectal Cancer Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Colorectal Cancer Therapeutics Introduction
11.7.4 Sanofi Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Regeneron
11.8.1 Regeneron Company Details
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Colorectal Cancer Therapeutics Introduction
11.8.4 Regeneron Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.8.5 Regeneron Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Colorectal Cancer Therapeutics Introduction
11.9.4 Bayer Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Onyx
11.10.1 Onyx Company Details
11.10.2 Onyx Business Overview
11.10.3 Onyx Colorectal Cancer Therapeutics Introduction
11.10.4 Onyx Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.10.5 Onyx Recent Development
11.11 Bristol-Myers Squib
11.11.1 Bristol-Myers Squib Company Details
11.11.2 Bristol-Myers Squib Business Overview
11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Introduction
11.11.4 Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.11.5 Bristol-Myers Squib Recent Development
11.12 Sumitomo Dainippon Pharma
11.12.1 Sumitomo Dainippon Pharma Company Details
11.12.2 Sumitomo Dainippon Pharma Business Overview
11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Introduction
11.12.4 Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.12.5 Sumitomo Dainippon Pharma Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Colorectal Cancer Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.13.5 Array BioPharma Recent Development
11.14 Hutchison MediPharma
11.14.1 Hutchison MediPharma Company Details
11.14.2 Hutchison MediPharma Business Overview
11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Introduction
11.14.4 Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.14.5 Hutchison MediPharma Recent Development
11.15 Jiangsu Hengrui Medicine
11.15.1 Jiangsu Hengrui Medicine Company Details
11.15.2 Jiangsu Hengrui Medicine Business Overview
11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Introduction
11.15.4 Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.15.5 Jiangsu Hengrui Medicine Recent Development
11.16 Jiangsu Chia-Tai Tianqing
11.16.1 Jiangsu Chia-Tai Tianqing Company Details
11.16.2 Jiangsu Chia-Tai Tianqing Business Overview
11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Introduction
11.16.4 Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.16.5 Jiangsu Chia-Tai Tianqing Recent Development
11.17 Suzhou Zelgen Biopharmaceuticals
11.17.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Introduction
11.17.4 Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2016-2021)
11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Continued….

Browse complete table of contents at -https://www.marketreportsworld.com/TOC/17280797

About Us: –

Market Reports World is the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

CONTACT US

Name: Ajay More

Email:  [email protected]

Phone: US +(1) 424 253 0807 /UK +(44) 203 239 8187